Cargando…
Will the epidemic of metabolic syndrome raise the prevalence of antiplatelet drug resistance?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783671/ https://www.ncbi.nlm.nih.gov/pubmed/24083139 http://dx.doi.org/10.4103/2229-516X.117047 |
| _version_ | 1782285691575599104 |
|---|---|
| author | Kones, Richard Rumana, Umme |
| author_facet | Kones, Richard Rumana, Umme |
| author_sort | Kones, Richard |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3783671 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | Medknow Publications & Media Pvt Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-37836712013-09-30 Will the epidemic of metabolic syndrome raise the prevalence of antiplatelet drug resistance? Kones, Richard Rumana, Umme Int J Appl Basic Med Res Editorial Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3783671/ /pubmed/24083139 http://dx.doi.org/10.4103/2229-516X.117047 Text en Copyright: © International Journal of Applied and Basic Medical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Kones, Richard Rumana, Umme Will the epidemic of metabolic syndrome raise the prevalence of antiplatelet drug resistance? |
| title | Will the epidemic of metabolic syndrome raise the prevalence of antiplatelet drug resistance? |
| title_full | Will the epidemic of metabolic syndrome raise the prevalence of antiplatelet drug resistance? |
| title_fullStr | Will the epidemic of metabolic syndrome raise the prevalence of antiplatelet drug resistance? |
| title_full_unstemmed | Will the epidemic of metabolic syndrome raise the prevalence of antiplatelet drug resistance? |
| title_short | Will the epidemic of metabolic syndrome raise the prevalence of antiplatelet drug resistance? |
| title_sort | will the epidemic of metabolic syndrome raise the prevalence of antiplatelet drug resistance? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783671/ https://www.ncbi.nlm.nih.gov/pubmed/24083139 http://dx.doi.org/10.4103/2229-516X.117047 |
| work_keys_str_mv | AT konesrichard willtheepidemicofmetabolicsyndromeraisetheprevalenceofantiplateletdrugresistance AT rumanaumme willtheepidemicofmetabolicsyndromeraisetheprevalenceofantiplateletdrugresistance |